跳到正文
Rohan Paul· @rohanpaul_ai · X·· 2026-08-16AI 评分50
AI 导读

Anthropic CEO Dario Amodei 打破沉默,预测 AI 约 5-10 年内可帮助治愈多数人类疾病,并称 AI 在结构上天然趋向权力集中,与监管无关。他主张监管应放缓前沿 AI 实验室、给小型挑战者追赶空间,并支持对前沿模型进行部署前测试。他认为开源权重无法解决集中问题,因算力与芯片仍稀缺,AI 公司需以真实突破而非营销赢得公众信任。

正文 · 原文

Dario Amodei broke his silence!

  • Predics that AI could help cure most human disease within roughly 5–10 years.
  • says AI is structurally prone to concentrating power, even without regulation.
  • He wants regulation designed to slow frontier AI labs while giving smaller challengers more room to catch up.
  • Argues open-weight AI does not solve concentration, because even with open-source serious capability still depends on scarce compute and chips.
  • He supports pre-deployment testing of frontier models, with open-weight models tested too once they approach frontier capability

- Says AI companies will not win public trust through better marketing. They need to deliver undeniable real-world breakthroughs first.

---

So now he just tied public trust to visible medical outcomes of AI, looks like Anthropic’s biology push is for real.

引用Dario Amodei@DarioAmodei
1/2 Thanks Gavin for an especially thoughtful exchange. I don't usually spend much time on social media but I wanted to engage here because it really brings out the heart of an important conversation. First, on regulation, I think that “either concentrate it in the hands of a chosen few companies and politicians via regulation or distribute it widely” is a false choice.  I know that there’s a sort of Silicon Valley shorthand where regulation = regulatory capture = concentration of power, but I’ve always found this to be an overly simplified picture of the world.  Many people outside this bubble think of regulation as something that constrains corporate power and benefits ordinary people.  I don’t necessarily agree with that perspective either, rather I think it’s complicated and really depends on what the “regulation” consists of.  But in particular I think that those in the “regulation = regulatory capture = concentration of power” frame often underrate the decentralizing power of objective and fair institutional processes.  A crude analogy is that the formal court system can sometimes feel stuffy and elitist, but it does a much better job of defending the rights of vulnerable individuals than the alternative, mob justice.  At their best, institutions can vest power in ideas rather than people, and thereby decentralize that power. This is why Anthropic has always made its policy proposals very carefully.  We try very hard to make proposals that disadvantage (slow down) frontier AI companies while *advantaging* smaller competitors.  California’s SB53 (which we supported), and even the much-maligned SB 1047 (which we were ambivalent on), completely exempt any company below a certain amount of revenue or model training costs from being covered at all (it was $500M for SB 53, lower for 1047 but we objected to that).  More recently the testing process we’ve advocated for at CAISI and the White House involves more rigorous tests for frontier models than off-frontier models — something that differentially advantages challengers.  Similarly, the “Pacing the Frontier” letter envisions (or at least Anthropic’s preferred implementation of it envisions) modulating the pace of the very best models while not constraining those who are catching up.  This hurts the business interests of the frontier labs and helps challengers, including open-weights! Overall my view is that AI is *structurally* a technology that tends to concentrate power, for reasons that have nothing to do with regulation (more to do with the extreme implications of the scaling laws).  Open-weights do help some with this but are nowhere near a sufficient solution because they simply shift the concentration somewhat to those with the most compute and chips (which are roughly the frontier labs plus maybe hardware providers).  By contrast I think the right “rules of the road” can simultaneously (a) address AI’s cyber/bio/alignment risks, (b) institutionally constrain the power of the frontier AI companies, and (c) leave room for open-weights models while also addressing the specific risks that they bring. BTW I do not think that the events of the last few months have “failed to result in [my] preferred regulatory path”.  The approach that the Trump administration is reported to be taking — pre-deployment testing for frontier models, and also testing of open-weights models when they get closer to the frontier — is one that I am very supportive of, though of course I have to see the details to be sure.  I am also supportive of Demis Hassabis’ ideas around a FINRA-like entity.  This contrasts with six months ago when most of the industry was still pushing for preemption of all state regulation and no apparent federal approach either.
在 X 查看被引用的帖子

来源:Rohan Paul · x.com